Regional Disparities in the Use and Demand for Digital Health Services for Autism Spectrum Disorder in China: Cross-Sectional Survey of Stakeholder Perspectives
Journal of Medical Internet Research · 2025
DOI: 10.2196/77157 ↗At a glance
Querschnittstudie in Journal of Medical Internet Research, 2025. Written by Mingyang Zou and 7 co-authors. Institution: Department of Children's and Adolescent Health, Public Health College, Harbin Medical University, Harbin, China. Major MEDLINE topics: Autism Spectrum Disorder, Health Services Needs and Demand, Telemedicine, Healthcare Disparities. Cited 4 times so far (Crossref); 34 references. The full text is freely available in PubMed Central.
Topics: Digitalisierung in der Pflege
Abstract (original language)
Background
Autism spectrum disorder (ASD) is a lifelong neurodevelopmental condition, the prevalence of which is increasing in China and worldwide. Digital health technologies offer promising solutions for improving screening, diagnosis, and rehabilitation of children with ASD, particularly in resource-limited settings. However, digital health technologies for ASD have not been adopted in China. Understanding utilization patterns, influencing factors, and user needs is essential to inform equitable, effective digital health strategies.
Objective
This study aimed to assess the current use, influencing factors, and perceived needs of digital health services among parents of children with ASD and rehabilitation therapists in 2 distinct provinces in China.
Methods
A cross-sectional survey was carried out between November 2023 and February 2024 in Heilongjiang and Fujian provinces. Purposive sampling recruited a total of 780 parents and 745 rehabilitation therapists to complete a structured questionnaire. Data were analyzed using descriptive statistics, stepwise multivariable logistic regression, and multiple response analysis.
Results
The use of digital health services was low among parents (46/780, 5.9%) and rehabilitation therapists (161/745, 21.6%), although the demand was substantially higher (621/780, 79.6% and 671/745, 90.0%, respectively). Among parents, higher use was positively associated with younger age (20-29 years), employment, lower income (≤CNY 3000/month [US $421.247/month]), and delayed ASD diagnosis (7-12 years old). Among rehabilitation therapists, male, special education background, and autism-specific training experience predicted higher use (all P
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Children's and Adolescent Health, Public Health College, Harbin Medical University, Harbin, China.
- Heilongjiang Province Key Laboratory of Child Development and Genetic Research, Harbin Medical University, Harbin, China.
- Beijing Normal-Hong Kong Baptist University, Zhuhai, China.
- Department of Developmental Behavioral Pediatrics, The Sixth Affiliated Hospital, Harbin Medical University, Harbin, China.
ORCID profiles: Mingyang Zou, Xiaomei Gong, Liwen Feng, Shengqi Li, Chenyang Lu, Zhuoqiong Liu, Caihong Sun, Lijie Wu
Cite
APA
Zou, M., Gong, X., Feng, L., Li, S., Lu, C., Liu, Z., Sun, C., & Wu, L. (2025). Regional Disparities in the Use and Demand for Digital Health Services for Autism Spectrum Disorder in China: Cross-Sectional Survey of Stakeholder Perspectives. Journal of Medical Internet Research. https://doi.org/10.2196/77157
Vancouver
Zou M, Gong X, Feng L, Li S, Lu C, Liu Z, et al. Regional Disparities in the Use and Demand for Digital Health Services for Autism Spectrum Disorder in China: Cross-Sectional Survey of Stakeholder Perspectives. Journal of Medical Internet Research. 2025. doi:10.2196/77157
BibTeX
@article{Zou2025,
author = {Zou, Mingyang and Gong, Xiaomei and Feng, Liwen and Li, Shengqi and Lu, Chenyang and Liu, Zhuoqiong and Sun, Caihong and Wu, Lijie},
title = {Regional Disparities in the Use and Demand for Digital Health Services for Autism Spectrum Disorder in China: Cross-Sectional Survey of Stakeholder Perspectives},
journal = {Journal of Medical Internet Research},
year = {2025},
doi = {10.2196/77157}
}
EUVIMED